Drug Profile
DP b99
Alternative Names: DP Bapta 99; DP-b99Latest Information Update: 14 Apr 2021
Price :
$50
*
At a glance
- Originator D-Pharm
- Class Anti-inflammatories; Antidementias; Antiepileptic drugs; Antimalarials; Antiparkinsonians; Antiprotozoals; Ethylenediamines; Neuroprotectants; Small molecules; Vascular disorder therapies
- Mechanism of Action Chelating agents; Matrix metalloproteinase 9 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued African trypanosomiasis; Alzheimer's disease; Brain injuries; CNS trauma; Epilepsy; Malaria; Neurodegenerative disorders; Pancreatitis; Parkinson's disease; Stroke
Most Recent Events
- 14 Apr 2021 Discontinued - Phase-I for Brain injuries in Israel (IV)
- 14 Apr 2021 Discontinued - Phase-I for CNS trauma (Prevention) in Israel (IV)
- 14 Apr 2021 Discontinued - Phase-II for Pancreatitis in Czech Republic, Slovakia, Ukraine (IV)